Is Prazosin Hydrochloride Capsule in shortage?
Prazosin Hydrochloride Capsule is listed by FDA as being discontinued by at least one maker (updated Apr 28, 2023).
Every listed package
FDA tracks shortages per package. What each maker reports, most recently updated first:
- Minipress, Capsule, 1 mg (NDC 0069-4310-71)
Discontinuation of the manufacture of the drug. Supply expected to exhaust in August 2023
Maker contact: 800-533-4535
- Minipress, Capsule, 2 mg (NDC 0069-4370-71)
Discontinuation of the manufacture of the drug. Supply expected to exhaust in September 2023
Maker contact: 800-533-4535
- Minipress, Capsule, 5 mg (NDC 0069-4380-71)
Discontinuation of the manufacture of the drug. Supply expected to exhaust in September 2023
Maker contact: 800-533-4535
Prazosin Hydrochloride Capsule shortage questions
Is Prazosin Hydrochloride Capsule in shortage?
Prazosin Hydrochloride Capsule is listed by FDA as being discontinued by at least one maker (updated Apr 28, 2023).
What should I do if I can’t get Prazosin Hydrochloride Capsule?
Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.
Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.